Abstract:Aim: To study the antibacterial effect of human a detensin-3 proprotein on Klebsiella pneumoniae and Escherichia coli, so as to provide references for the study on the antibacterial mechanism of defensin. Methods: The experiment was performed at Liu Jian-hua's laboratory of Life Science and Technology College, Shanghai Jiao Tong University from November 2005 to September 2006. The genes coding human α defensin-3 proprotein sequence were cloned to vector pDEST17, and the resulting vectors were transformed into E coli DE3 cells. The human a defensin-3 proproteins were obtained through induction in vitro and affinity chromatography purification. The antibacterial activity of the proprotein was analyzed according to the proportion of survived Klebsiella pneumoniae and Escherichia coli under proprotein at different concentrations and the lethal doses of a defensin-3 proproteins inducing 50%, 90% and 99% microbial lethality. Results: 1 Approximately 12 mg purified fusion proteins were obtained from 1 L culture medium with the renaturing rate of 15% to 20%. 2 The survival rates of Klebsiella pneumoniae were 50%, 33%, 10% and 4% under 5, 10, 15 and 30 mg/L proteins; the rates of Escherichia co# were 50%, 10%, 5% and 1% under 10, 20, 30 and 45 mg/L proteins. 3 The concentrations of recombinant proteins resulting in 50% and 99% microbial lethality for Klebsiella pneumoniae were 5 and 35 mg/L respectively, while those for E.coli DH5 α were 10 and 45 mg/L. Conclusion: Recombinant and purified human α defensin-3 proprotein could kill both Klebsiella pneumoniae and Escherichia coli DH5 α efficiently.

Production of Bioactive Human β -defensin-3 in Escherichia coli by Soluble Fusion Expression

Production Of Bioactive Human Beta-Defensin-3 In Escherichia Coli By Soluble Fusion Expression

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Tandem Repeat Mhbd2 Gene Enhance the Soluble Fusion Expression of Hbd2 in Escherichia Coli

Fusion expression of human beta-defensin-2 from multiple joined genes in Escherichia coli.

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Fusion Expression of Human β-Defensin DEFB113 and Its Biological Activities

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli Using SUMO Fusion Partner

Efficient production of human beta-defensin 2 (HBD2) in Escherichia coli

Expression of human β-defensin-2 with multiple joined genes in Escherichia coli

High efficiency preparation of bioactive human α-defensin 6 in Escherichia coli Origami(DE3)pLysS by soluble fusion expression

Expression of human beta-defensin-2 with multiple joined genes in Escherichia coli.

Antibacterial role of human alpha-defensin-3 proprotein in Klebsiella pneumoniae and Escherichia coli

Expression of Human Transforming Growth Factor β3 in E.coli BL21

[Construction of HBD-3 Gene Mammary-Specific Expression Vector and Eukaryotic Expression].

Antimicrobial Characterization of Human -Defensin 3 Derivatives